Skip to content

The value of serum ischemia-modified albumin in early diagnosis of acute aortic dissection

The value of serum ischemia-modified albumin in early diagnosis of acute aortic dissection

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039546
Enrollment
Unknown
Registered
2020-10-31
Start date
2020-11-10
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic dissection

Interventions

Gold Standard:Aortic CTA
Index test:Ischemia-modifying&#32
protein&#32

Sponsors

The Second Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: All AAD patients need to be diagnosed by aortic CTA; AMI patients are diagnosed through coronary angiography or cardiology treatment, and AAD is excluded; APE patients are diagnosed through pulmonary artery CTA; AAD diagnostic criteria refer to the 2014 European Society of Cardiology "Aortic Disease Guidelines for Diagnosis and Treatment", APE diagnosis refers to the 2019 "Guidelines for Diagnosis and Treatment of APE" in 2019. The diagnostic criteria of AMI refer to the 2018 "Guidelines for the Diagnosis and Treatment of Acute ST-segment Elevation Myocardial Infarction". NNCP patients were excluded from cardiogenic chest pain such as AAD, AMI, and APE.

Exclusion criteria

Exclusion criteria: Patients younger than 18 years old and terminal patients (including patients with advanced stages of various types of tumors, terminal liver and kidney diseases, patients with chest pain more than 48 hours onset, pregnant patients, patients themselves or their family members who are unwilling to participate in the experiment).

Design outcomes

Primary

MeasureTime frame
IMA;SEN, SPE, ACC, AUC of ROC;

Secondary

MeasureTime frame
D-dimer;

Countries

China

Contacts

Public ContactChai Xiangping

The Second Xiangya Hospital, Central South University

345060078@qq.com+86 17582497442

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026